Total Collaborative Study Protocol_Solus One Salmonella v1 1
calculate the MPN value with 95% Confidence interval levels (7).
Prior to inoculation of shredded cheddar cheese and pasteurized liquid egg matrixes, the respective
broth culture inoculums were heat stressed for 10 ± 1 min at 50 ± 1°C in a water bath. The heat stressed
Salmonella starter cultures were subsequently diluted in BHI broth, added to the respective matrixes
and subsequently mixed. Following inoculation, a bulk lot of the matrix was homogenized by hand and
held for 48–72 h at 2–8°C prior to analysis, thereby allowing time for the target organism to equilibrate
within the sample. At these low and high inoculum levels, fractional positives or consistently positive
results at the time of sampling were anticipated.
The degree of injury of the culture was estimated by plating an aliquot of diluted culture onto xylose
lysine deoxycholate agar (XLD) and Tryptic Soy agar (TSA). The agars were incubated for 18–24 h at 35 ±
1°C before colonies were enumerated. The degree of injury was estimated as: ൬1 െ ௦௧ ௦௧ ൰ 100 Where = number of colonies on selective agar
= number of colonies on non‐selective agar
For the inoculation of a non‐fat dry milk (NFDM) powder matrix, a lyophilized culture was used. The
lyophilized culture was prepared by transferring a single Salmonella colony from SBA into BHI broth for
18–24 h at 35 ± 2°C. The culture was then diluted in a sterile cryo‐protectant, reconstituted NFDM blend
and freeze dried for 48–72 h. The lyophilized Salmonella culture was subsequently diluted in powdered
NFDM and used to inoculate a bulk lot of the matrix at levels that would yield fractional positives or
consistently positive results at the time of sampling. Following inoculation, a bulk lot of the NFDM
powder matrix was homogenized by hand and held for two weeks at room temperature (15–25°C) prior
to analysis, thereby allowing time for the target organism to equilibrate within the sample.
For stainless steel environmental surfaces, 4” x 4” areas were co‐inoculated with 0.25 mL diluted
Page 29 of 47
Made with FlippingBook - Online Brochure Maker